Stock comparison
LeMaitre Vascular
TransMedics Group
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
TMDX
TransMedics Group
Market cap
$2.18B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | TMDX | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 55D | LMAT |
| Benjamin Graham | 89A | 61D | LMAT |
| Philip Fisher | 81C | 56C | LMAT |
| Peter Lynch | 67B | 84C | TMDX |
| Joel Greenblatt | 56D | 48D | LMAT |
| Charlie Munger | 68D | 54D | LMAT |
| Terry Smith | 69D | 47D | LMAT |
Side-by-side metrics
| Metric | LMAT | TMDX |
|---|---|---|
| Market cap | $2.32B | $2.18B |
| P/E (TTM) | 37.1x | 12.6x |
| EV/EBIT | 36.6x | 23.4x |
| ROIC (TTM) | 9.43% | 6.94% |
| Gross margin | 72.39% | 59.09% |
| Net margin | 24.35% | 27.04% |
| Revenue CAGR 5y | 12.75% | 111.5% |
| EPS CAGR 5y | 19.04% | - |
| Debt / Equity | 0.5x | 1.7x |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Debt / Equity0.5xvs 1.7x+72%
- ROIC (TTM)9.43%vs 6.94%+26%
- Gross margin72.39%vs 59.09%+18%
TMDX leads on
- Revenue CAGR 5y111.5%vs 12.75%+89%
- P/E (TTM)12.6xvs 37.1x+66%
- EV/EBIT23.4xvs 36.6x+36%
- Net margin27.04%vs 24.35%+10%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.